A novel integrin α5β1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor

Biochemical and Biophysical Research Communications

Volumn 377, Issue 4, 2008, Pages 1288-1293

  Kim, Eung Yoon ^a   Bang, Ji Young ^a   Chang, Soo Ik ^b   Kang, In Cheol ^a  

^a Hoseo University   (South Korea)

^b Research Institute for Natural Sciences   (South Korea)

Author keywords

Angiogenesis; Integrin 5 1; Protein microarray; ProteoChip

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; FIBRONECTIN; PEPTIDE LIBRARY; SYNTHETIC PEPTIDE; VERY LATE ACTIVATION ANTIGEN 5; OLIGOPEPTIDE; UNCLASSIFIED DRUG; VALYL ISOLEUCYL LEUCYL VALYL LEUCYL PHENYLALANINE; VALYL-ISOLEUCYL-LEUCYL-VALYL-LEUCYL-PHENYLALANINE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; COMPETITIVE INHIBITION; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IC 50; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; SCREENING; UMBILICAL VEIN; AMINO ACID SEQUENCE; CELL CULTURE; CELL MOTION; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ISOLATION AND PURIFICATION;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; HUMANS; INTEGRIN ALPHA5BETA1; OLIGOPEPTIDES; PROTEIN ARRAY ANALYSIS;

EID: 56349146440     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.166     Document Type: Article

References (23)

1. Francis S.E., Goh K.L., Hodivala-Dilke K., Bader B.L., Stark M., Davidson D., and Hynes R.O. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 927-933
2. Kita D., Takino T., Nakada M., Takahashi T., Yamashita J., and Sato H. Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line. Cancer Res. 61 (2001) 7985-7991
3. Wickstrom S.A., Alitalo K., and Keski-Oja J. An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J. Biol. Chem. 279 (2004) 20178-20185
4. Kim S., Bell K., Mousa S.A., and Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 156 (2000) 1345-1362
5. Cue D., Southern S.O., Southern P.J., Prabhakar J., Lorelli W., Smallheer J.M., Mousa S.A., and Cleary P.P. A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes. Proc. Natl. Acad. Sci. USA 97 (2000) 2858-2863
6. Smallheer J.M., Weigelt C.A., Woerner F.J., Wells J.S., Daneker W.F., Mousa S.A., Wexler R.R., and Jadhav P.K. Synthesis and biological evaluation of nonpeptide integrin antagonists containing spirocyclic scaffolds. Bioorg. Med. Chem. Lett. 14 (2004) 383-387
7. Livant D.L., Brabec R.K., Pienta K.J., Allen D.L., Kurachi K., Markwart S., and Upadhyaya A. Anti-invasive Antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res. 60 (2000) 309-320
8. van Golen K.L., Bao L., Brewer G.J., Pienta K.J., Kamradt J.M., Livant D.L., and Merajver S.D. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia 4 (2002) 373-379
9. Stoeltzing O., Liu W., Reinmuth N., Fan F., Parry G.C., Parikh A.A., McCarty M.F., Bucana C.D., Mazar A.P., and Ellis L.M. Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int. J. Cancer 104 (2003) 496-503
10. Marinelli L., Meyer A., Heckmann D., Lavecchia A., Novellino E., and Kessler H. Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonists. J. Med. Chem. 48 (2005) 4204-4207
11. Kim S., Bakre M., Yin H., and Varner J.A. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J. Clin. Invest. 110 (2002) 933-941
12. Lee Y., Kang D.K., Chang S.I., Han M.H., and Kang I.C. High-throughput screening of novel peptide inhibitors of an integrin receptor from the hexapeptide library by using a protein microarray chip. J. Biomol. Screen. 9 (2004) 687-694
13. Bang J.I., Kim E.Y., Seong N.S., Shin Y.S., and Kang I.C. ProteoChip-based library screening of integrin alpha5beta1 antagonists from Korean medicinal plant extracts. Arch. Pharm. Res. 30 (2007) 1584-1589
14. Sukhanov S., and Delafontaine P. Protein chip-based microarray profiling of oxidized low density lipoprotein-treated cells. Proteomics 5 (2005) 1274-1280
15. Cattaneo M.G., Pola S., Francescato P., Chillemi F., and Vicentini L.M. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo. Exp. Cell Res. 283 (2003) 230-236
16. Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., and Cheresh D.A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 (1994) 1157-1164
17. Ferguson T.A., Mizutani H., and Kupper T.S. Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo. Proc. Natl. Acad. Sci. USA 88 (1991) 8072-8076
18. Lee Y., Lee E.K., Cho Y.W., Matsui T., Kang I.C., Kim T.S., and Han M.H. ProteoChip: a highly sensitive protein microarray prepared by a novel method of protein immobilization for application of protein-protein interaction studies. Proteomics 3 (2003) 2289-2304
19. Humphries M.J., Olden K., and Yamada K.M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 233 (1986) 467-470
20. Iwamoto Y., Robey F.A., Graf J., Sasaki M., Kleinman H.K., Yamada Y., and Martin G.R. A synthetic laminin pentapeptide, inhibits experimental metastasis formation, YIGSR. Science 238 (1987) 1132-1134
21. Wayner E.A., Garcia-Pardo A., Humphries M.J., McDonald J.A., and Carter W.G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109 (1989) 1321-1330
22. Mould A.P., Wheldon L.A., Komoriya A., Wayner E.A., Yamada K.M., and Humphries M.J. Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin alpha 4 beta 1. J. Biol. Chem. 265 (1990) 4020-4024
23. Komoriya A., Green L.J., Mervic M., Yamada S.S., Yamada K.M., and Humphries M.J. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J. Biol. Chem. 266 (1991) 15075-15079